technetium tc-99m mertiatide kit
Trade name: Technescan MAG3
Small moleculeapprovedImaging agent
Approved
Jun 15, 1990
Clinical trial activity
0 trials · 0 clinical orgs · 7 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1990s
- Jun 15, 1990
Curium Pharma — Earliest FDA Approval
- Jun 15, 1990
Curium Pharma — NDA Secondary Org
- Jun 15, 1990
Curium Pharma — NDA Organization
2010s
- Jul 12, 2019
Sun Pharmaceuticals — Marketing Organization
- Jul 12, 2019
Pharmalucence — Marketing Organization
2020s
- Feb 6, 2020
Sommer Pharmaceuticals — Marketing Organization
- Feb 6, 2020
MEDI-RADIOPHARMA — Marketing Organization
- Jan 30, 2023
Jubilant DraxImage Inc. — Marketing Organization
- Jan 30, 2023
Jubilant Innovation Ltd. — NDA Secondary Org
Indications
Approved for
Mechanism of action
- contrast mediumRadiopaque
contrast medium radiopaque
Approval history
- approvedJun 15, 1990
Chemistry & pharmacology
- Mol. weight
- 419.12 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
- Imaging
- 99-technetiium
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL2107488 ↗
Also known as
- tc-mag3
- tc-mag3
- technescan mag3
- technescan mag3
- technescan mag3
- technetium (99mtc) mertiatide
- technetium (99mtc) mertiatide
- technetium tc 99m mertiatide
- technetium tc 99m mertiatide
- technetium tc-99m mertiatide kit
- technetium tc-99m mertiatide kit
- technetium tc-99m mertiatide kit
Organizations
Marketing (8)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Curium Pharma | For profit | NDA2 | Jun 15, 1990 |
| Curium Pharma | For profit | NDA | Jun 15, 1990 |
| Jubilant DraxImage Inc. | For profit | MKTG | Jan 30, 2023 |
| Jubilant Innovation Ltd. | For profit | NDA2 | Jan 30, 2023 |
| MEDI-RADIOPHARMA | For profit | MKTG | Feb 6, 2020 |
| Pharmalucence | For profit | MKTG | Jul 12, 2019 |
| Sommer Pharmaceuticals | For profit | MKTG | Feb 6, 2020 |
| Sun Pharmaceuticals | For profit | MKTG | Jul 12, 2019 |